Terms: = Ovarian cancer AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217 AND Treatment
3 results:
1. TGFαL3-seb fusion protein as an anticancer against ovarian cancer.
Maleki F; Sadeghifard N; Sedighian H; Bakhtiyari S; Hosseini HM; Fooladi AAI
Eur J Pharmacol; 2020 Mar; 870():172919. PubMed ID: 31935394
[TBL] [Abstract] [Full Text] [Related]
2. A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients.
Battaglia A; Fossati M; Buzzonetti A; Scambia G; Fattorossi A
Immunol Lett; 2017 Nov; 191():35-39. PubMed ID: 28919454
[TBL] [Abstract] [Full Text] [Related]
3. Texosome-anchored superantigen triggers apoptosis in original ovarian cancer cells.
Mahmoodzadeh Hosseini H; Soleimanirad J; Mehdizadeh Aghdam E; Amin M; Imani Fooladi AA
Med Oncol; 2015 Jan; 32(1):409. PubMed ID: 25452173
[TBL] [Abstract] [Full Text] [Related]
